FI932490A - Underenhetsvaccin mot Neisseria meningitidis-infektioner och motsvarande underenheter i rent tillstaond - Google Patents

Underenhetsvaccin mot Neisseria meningitidis-infektioner och motsvarande underenheter i rent tillstaond Download PDF

Info

Publication number
FI932490A
FI932490A FI932490A FI932490A FI932490A FI 932490 A FI932490 A FI 932490A FI 932490 A FI932490 A FI 932490A FI 932490 A FI932490 A FI 932490A FI 932490 A FI932490 A FI 932490A
Authority
FI
Finland
Prior art keywords
pct
underenhetsvaccin
underenheter
tillstaond
infektioner
Prior art date
Application number
FI932490A
Other languages
English (en)
Other versions
FI107262B (fi
FI932490A0 (fi
Inventor
Marie-Jose Quentin-Millet
Ling Lissolo
Original Assignee
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Merieux Serums Vacc filed Critical Pasteur Merieux Serums Vacc
Publication of FI932490A publication Critical patent/FI932490A/fi
Publication of FI932490A0 publication Critical patent/FI932490A0/fi
Application granted granted Critical
Publication of FI107262B publication Critical patent/FI107262B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/871Neisseria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI932490A 1991-10-03 1993-06-01 Menetelmä rokotekoostumuksen valmistamiseksi Neisseria meningitidis-infektioita vastaan FI107262B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9112176 1991-10-03
FR9112176A FR2682114B1 (fr) 1991-10-03 1991-10-03 Vaccin de sous-unite contre les infections a neisseria meningitidis et sous-unites correspondantes a l'etat purifie.
PCT/FR1992/000904 WO1993007172A1 (fr) 1991-10-03 1992-09-29 Vaccin de sous-unite contre les infections a neisseriameningitidis et sous-unites correspondantes a l'etat purifie
FR9200904 1992-09-29

Publications (3)

Publication Number Publication Date
FI932490A true FI932490A (fi) 1993-06-01
FI932490A0 FI932490A0 (fi) 1993-06-01
FI107262B FI107262B (fi) 2001-06-29

Family

ID=9417548

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932490A FI107262B (fi) 1991-10-03 1993-06-01 Menetelmä rokotekoostumuksen valmistamiseksi Neisseria meningitidis-infektioita vastaan

Country Status (15)

Country Link
US (2) US5618540A (fi)
EP (1) EP0560969B1 (fi)
JP (1) JPH06503364A (fi)
AT (1) ATE174930T1 (fi)
AU (1) AU668522B2 (fi)
CA (1) CA2096411A1 (fi)
DE (1) DE69227984T2 (fi)
DK (1) DK0560969T3 (fi)
ES (1) ES2128358T3 (fi)
FI (1) FI107262B (fi)
FR (1) FR2682114B1 (fi)
GR (1) GR3029580T3 (fi)
HU (1) HU219762B (fi)
NO (1) NO309865B1 (fi)
WO (1) WO1993007172A1 (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2692592B1 (fr) * 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
US5928647A (en) * 1993-01-11 1999-07-27 Dana-Farber Cancer Institute Inducing cytotoxic T lymphocyte responses
RU2194757C2 (ru) * 1993-11-08 2002-12-20 Коннот Лабораториз Лимитед ФРАГМЕНТ ДНК, КОДИРУЮЩИЙ ФРАГМЕНТ БЕЛКА РЕЦЕПТОРА ТРАНСФЕРРИНА ШТАММА Haemophilus (ВАРИАНТЫ), ПЛАЗМИДНЫЙ ВЕКТОР (ВАРИАНТЫ), РЕКОМБИНАНТНЫЙ БЕЛОК (ВАРИАНТЫ), ВЫДЕЛЕННЫЙ И ОЧИЩЕННЫЙ БЕЛОК (ВАРИАНТЫ), ИММУНОГЕННАЯ КОМПОЗИЦИЯ И СПОСОБ ПОЛУЧЕНИЯ ВЫДЕЛЕННОГО И ОЧИЩЕННОГО БЕЛКА
FR2720408B1 (fr) * 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
US6290970B1 (en) * 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
FR2785293B1 (fr) * 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
AU2107400A (en) * 1999-01-15 2000-08-01 Smithkline Beecham Biologicals (Sa) Neisseria meningitidis antigen
NZ597007A (en) 2009-05-14 2013-09-27 Sanofi Pasteur Meningococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis
WO2011024072A2 (en) * 2009-08-27 2011-03-03 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
KR102507993B1 (ko) 2013-12-02 2023-03-15 엔지니어드 안티젠즈 인코포레이티드 박테리아 표면 수용체 단백질로부터 유래된 면역원성 조성물 및 백신

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5141743A (en) * 1989-04-27 1992-08-25 University Technologies International, Inc. Method for isolating and purifying transferrin and lactoferrin receptor proteins and vaccines containing the same
DE69133334T2 (de) * 1990-08-23 2004-05-13 University Of North Carolina At Chapel Hill Transferrin bindende proteine aus neisseria-gonorrhoeae und neisseria-meningitidis
FR2682041B1 (fr) * 1991-10-03 1994-01-14 Pasteur Merieux Serums Vaccins Vaccin contre les infections a neisseria meningitidis.

Also Published As

Publication number Publication date
JPH06503364A (ja) 1994-04-14
HU9301631D0 (en) 1993-10-28
EP0560969B1 (fr) 1998-12-23
HU219762B (hu) 2001-07-30
FI107262B (fi) 2001-06-29
EP0560969A1 (fr) 1993-09-22
ES2128358T3 (es) 1999-05-16
DK0560969T3 (da) 1999-08-23
AU2764092A (en) 1993-05-03
HUT69929A (en) 1995-09-28
CA2096411A1 (en) 1993-04-04
DE69227984T2 (de) 1999-05-12
NO932009D0 (no) 1993-06-02
GR3029580T3 (en) 1999-06-30
ATE174930T1 (de) 1999-01-15
WO1993007172A1 (fr) 1993-04-15
NO309865B1 (no) 2001-04-09
FR2682114A1 (fr) 1993-04-09
US5928650A (en) 1999-07-27
FR2682114B1 (fr) 1996-02-23
FI932490A0 (fi) 1993-06-01
DE69227984D1 (de) 1999-02-04
AU668522B2 (en) 1996-05-09
US5618540A (en) 1997-04-08
NO932009L (no) 1993-07-20

Similar Documents

Publication Publication Date Title
FI963398A0 (fi) Kielenalainen tai poskensisäinen farmaseuttinen koostumus
NO981436D0 (no) Farmasöytiske angiostatiske dipeptidsammensetninger og anvendelse derav
ES2090696T3 (es) Vacunas contra infecciones de neisseria meningitidis.
GB2295317B (en) Liquid composition containing ondansetron
FI932490A0 (fi) Underenhetsvaccin mot Neisseria meningitidis-infektioner och motsvarande underenheter i rent tillstaond
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
IL108750A (en) Pharmaceutical cognition enhancing compositions containing 1,3-dialiphatic-8-(phenylalkyl or ludanyl) xanthines as selective adenosine receptor agents
ATE150030T1 (de) Ureidoacetamid-derivate,irhe herstellung und sie enthaltende medikamente